Hilde Rosing Selected Research

5'-deoxy-5-fluorocytidine

12/2019	Pharmacokinetics of Capecitabine and Four Metabolites in a Heterogeneous Population of Cancer Patients: A Comprehensive Analysis.
4/2010	A new, validated HPLC-MS/MS method for the simultaneous determination of the anti-cancer agent capecitabine and its metabolites: 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, 5-fluorouracil and 5-fluorodihydrouracil, in human plasma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hilde Rosing Research Topics

Disease

57	Neoplasms (Cancer) 01/2022 - 01/2002
24	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2002
8	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 10/2015
5	Sarcoma (Soft Tissue Sarcoma) 11/2021 - 05/2007
5	Renal Cell Carcinoma (Grawitz Tumor) 05/2020 - 01/2012
4	Nausea 04/2022 - 07/2009
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 04/2004
3	Dihydropyrimidine Dehydrogenase Deficiency 01/2022 - 07/2016
3	Neutropenia 01/2022 - 05/2002
3	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2019
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2020
3	Melanoma (Melanoma, Malignant) 04/2020 - 01/2014
3	Diarrhea 01/2020 - 11/2019
3	Hematologic Neoplasms (Hematological Malignancy) 03/2019 - 03/2013
3	Ovarian Neoplasms (Ovarian Cancer) 04/2008 - 02/2003
2	Visceral Leishmaniasis (Kala Azar) 08/2022 - 01/2022
2	Leishmaniasis 08/2022 - 01/2022
2	Vomiting 04/2022 - 07/2009
2	Exanthema (Rash) 01/2020 - 01/2020
2	Neoplasm Metastasis (Metastasis) 06/2018 - 10/2015
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2016 - 10/2016
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2016 - 03/2014
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2014 - 06/2012
2	Phototoxic Dermatitis (Phototoxicity) 06/2007 - 11/2002
1	Neglected Diseases 08/2022
1	Parasitic Diseases (Parasitic Disease) 01/2022
1	Stomatitis 01/2022
1	COVID-19 10/2021

Drug/Important Bio-Agent (IBA)

11	Pharmaceutical PreparationsIBA 01/2022 - 08/2002
10	Docetaxel (Taxotere)FDA Link 01/2022 - 02/2003
10	Proteins (Proteins, Gene)FDA Link 05/2020 - 11/2002
8	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2020 - 10/2004
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 04/2004
5	Tamoxifen FDA LinkGeneric 10/2021 - 06/2011
5	Capecitabine (Xeloda)FDA Link 05/2020 - 04/2010
5	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2012
4	Cytochrome P-450 CYP3AIBA 01/2022 - 09/2013
4	pazopanib FDA Link 11/2021 - 01/2016
4	Imatinib Mesylate (Gleevec)FDA Link 08/2020 - 04/2009
4	Fluorouracil (Carac)FDA LinkGeneric 05/2020 - 04/2010
4	ElacridarIBA 10/2015 - 10/2004
4	TrabectedinIBA 12/2009 - 01/2002
3	Hormones (Hormone)IBA 01/2022 - 06/2019
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2022 - 10/2020
3	UracilIBA 01/2022 - 07/2016
3	Abiraterone AcetateIBA 01/2021 - 06/2019
3	Ritonavir (Norvir)FDA Link 01/2021 - 06/2009
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 01/2020
3	enzalutamideIBA 12/2019 - 01/2019
3	taxaneIBA 10/2015 - 04/2004
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2022 - 01/2014
2	abemaciclibIBA 01/2022 - 09/2021
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 04/2006
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 09/2017
2	abirateroneIBA 01/2021 - 10/2019
2	Monoclonal AntibodiesIBA 10/2020 - 08/2009
2	guadecitabineIBA 01/2020 - 03/2019
2	5'-deoxy-5-fluorocytidineIBA 12/2019 - 04/2010
2	AndrogensIBA 12/2019 - 06/2019
2	doxifluridineIBA 12/2019 - 04/2010
2	DNA (Deoxyribonucleic Acid)IBA 11/2019 - 07/2009
2	dihydrouracilIBA 06/2018 - 07/2016
2	PlatinumIBA 09/2017 - 05/2002
2	Carboplatin (JM8)FDA LinkGeneric 09/2017 - 07/2009
2	4-hydroxy-N-desmethyltamoxifenIBA 01/2017 - 06/2011
2	HomoharringtonineIBA 12/2016 - 10/2016
2	VemurafenibIBA 10/2016 - 01/2014
2	Bendamustine Hydrochloride FDA Link 03/2013 - 07/2012
2	Trastuzumab (Herceptin)FDA Link 01/2013 - 08/2009
2	NucleosidesIBA 06/2012 - 03/2011
2	Topotecan (Hycamtin)FDA LinkGeneric 07/2009 - 05/2002
2	Gemcitabine FDA Link 06/2008 - 01/2007
2	Antineoplastic Agents (Antineoplastics)IBA 01/2007 - 09/2002
2	N- (3- chloro- 7- indolyl)- 1,4- benzenedisulphonamide (E7070)IBA 08/2005 - 09/2002
1	liposomal amphotericin B FDA Link 08/2022
1	Antiparasitic Agents (Antiparasitics)IBA 08/2022
1	Amphotericin B (Amphotericin)FDA LinkGeneric 08/2022
1	Aprepitant (Emend)FDA Link 04/2022
1	miltefosine (Impavido)IBA 01/2022
1	palbociclibIBA 01/2022
1	Cytochrome P-450 CYP3A InhibitorsIBA 01/2022
1	EnzymesIBA 01/2022
1	Everolimus FDA Link 01/2022
1	Erythromycin (Erycette)FDA LinkGeneric 01/2022
1	niraparibIBA 12/2021
1	Peptides (Polypeptides)IBA 10/2021
1	Immunoglobulin M (IgM)IBA 10/2021
1	Estradiol (Delestrogen)FDA LinkGeneric 10/2021
1	Messenger RNA (mRNA)IBA 10/2021
1	Cyclin-Dependent Kinase 4IBA 09/2021
1	CrizotinibIBA 01/2021
1	AZD 6244IBA 01/2021

Therapy/Procedure

10	Therapeutics 10/2021 - 06/2008
6	Castration 01/2022 - 01/2019
5	Drug Therapy (Chemotherapy) 04/2022 - 02/2003
3	Intravenous Administration 08/2020 - 05/2007
2	Radiotherapy 11/2021 - 11/2018
2	Oral Administration 01/2020 - 06/2008
2	Renal Dialysis (Hemodialysis) 01/2019 - 01/2016
2	Cytoreduction Surgical Procedures 04/2008 - 02/2003